The majority of the Panel from the 2013 St Gallen voted that a threshold of ≥20% is clearly indicative of high Ki-67 status, whereas a minority still questioned this value and the role of Ki-67 in breast cancer treatment decisions. The gene discussed is MKI67; the disease is breast cancer.